Treatment of calmodulinopathy with verapamil

Gregory Webster*, Zachary J. Schoppen, Alfred L. George

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


Pathological variants in genes encoding calmodulin are associated with severe clinical presentations, including recurrent ventricular fibrillation and sudden death. Beta-receptor antagonists (beta-blockers) and sodium-channel antagonists have been reported as pharmacotherapies in these disorders; however, recent data have demonstrated the importance of derangements in calcium channel inactivation. We report a sustained attempt to use calcium-channel antagonists to treat calmodulinopathy and review the treatment strategies reported in the literature to date.

Original languageEnglish (US)
Article numberbcr-2017-220568
JournalBMJ case reports
StatePublished - 2017


  • arrhythmias
  • cardiovascular medicine

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Treatment of calmodulinopathy with verapamil'. Together they form a unique fingerprint.

Cite this